**14. Trauma**


undergo inpatient rehabilitation, ACCP suggest continuing thromboprophylaxis with LMWH or a VKA (target INK, 2.5; range, 2.0 to 3.0) (Grade 2C).

### **15. References**

190 Venous Thrombosis – Principles and Practice










primary thromboprophylaxis to try to improve survival (Grade IB).

and frequent ambulation should be forced (Grade 1B).

LMWH, LDUH, fondaparinux, IPC, or GCS (all Grade 1C).

thromboprophylaxis or no thromboprophylaxis (Grade 1C).

filter as thromboprophylaxis (Grade 1C).

thrombosis.

**14. Trauma** 

IB).

(Grade 1C).

**13. Laparoscopic surgery** 

possible (Grade 1A).

recommendations in the relevant surgical subsections. 7.0.2. For cancer patients who are bedridden with an acute medical illness, ACCP recommend routine thromboprophylaxis as for other high-risk medical patients (Grade 1A). Refer to the recommendations in Section 6.0. 7.0.3. For cancer patients with indwelling central venous catheters, ACCP recommend that clinicians not use either prophylactic doses of LMWH (Grade IB), or minidose warfarin (Grade IB) to try to prevent catheter-related


Approaching Venous Thrombosis in General Surgery Patients 193

[29] Heit JA, Silverstein MD, Mohr DN, et al. Predictors of survival after deep vein

[30] Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with

[31] Martino MA, Williamson E, Siegfried S, et al. Diagnosing pulmonary embolism:

[32] Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes.

[33] Kakkar AK, Levine M, Pinedo HM, et al. Venous thrombosis in cancer patients:

[34] Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology

[35] *NCCN Clinical Practice Guidelines in Oncology™ Venous Thromboembolic Disease.* V2.2008.

[36] Amin A, Stemkowski S, Lin J, Yang G. Appropriate thromboprophylaxis in hospitalized cancer patients. *Clin Adv Hematol Oncol.* 2008;6(12):910-920. [37] Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH. Venous

[38] Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous

[39] Colditz GA, Tuden RL, Oster G (1986) Rates of venous thrombosis after general surgery: combined results of randomised clinical trials. Lancet 2:143–146 [40] Denstman F, Lowry A, Vernava A et al (2000) Practice parameters for the prevention of

[41] Torngren S, Rieger A (1982) Prophylaxis of deep venous thrombosis in colorectal

[42] Huber O, Bounameaux H, Borst F et al (1992) Postoperative pulmonary embolism after

[43] McLeod RS (1996) The risk of thromboembolism in patients undergoing colorectal

[44] Rasmussen MS (2002) Preventing thromboembolic complications in cancer patients

[45] Rasmussen MS, Jorgensen LN, Wille-Jorgensen P et al (2006) Prolonged prophylaxis

after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev 28:141–

with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study.

hospital discharge. An underestimated risk. Arch Surg 127:310–313

insights from the FRONTLINE survey. *Oncologist.* 2003:8:381-388.

treatment in patients with cancer. *J Clin Oncol.* 2007:25:5490-5505.

http://www.nccn.org/professionals/physician\_gls/PDF/vte.pdf.

venous thromboembolism. *N EnglJMed.* 2000:343:1846-1850.

*Intern Med.* 1999:159:445-453.

*Gynecol Oncol.* 2005:98:289-293.

*Circulation.* 2003:107(23 suppl 1):I17-I21.

survival. J Clin Oncol. 2006;24(7):1112-8.

surgery. Dis Colon Rectum 25:563–566

surgery. Drugs 52(Suppl 7):38–41

J Thromb Haemost 4:2384–2390

144

Practice Guidelines (8th Edition). Chest 133:381S–453S

Colon and Rectal Surgeons. Dis Colon Rectum 43:1037–1047

thrombosis and pulmonary embolism: a population-based, cohort study. *Arch* 

experience with spiral CT pulmonary angiography in gynecologic oncology.

Guideline: recommendations for venous thromboembolism prophylaxis and

Copyright 2008 by the National Comprehensive Cancer Network. Available at:

thromboembolism in patients with colorectal cancer: incidence and effect on

thromboembolism: American College of Chest Physicians Evidence-Based Clinical

venous thromboembolism. The Standards Task Force of the American Society of


[13] Prandoni P, Lensing AW, Piccioli A, et al: Recurrent venous thromboembolism and

[14] Elting LS, Escalante CP, Cooksley C, et al: Outcomes and cost of deep

[15] Zangari M, Barlogie B, Anaissie E, et al: Deep vein thrombosis in patients

[16] Nalluri SR, Chu D, Keresztes R, et al: Risk of venous thromboembolism with the

[17] Sousou T, Khorana A. Identifying cancer patients at risk for venous thromboembolism.

[18] Aki EA, Rohilla S, Barba M, et al. Anticoagulation for the initial treatment of venous

[19] Lee A, Levine M. The thrombophilic state induced by therapeutic agents in the cancer

[20] Deitcher SR. Cancer and thrombosis: mechanisms and treatment. *J Thromb* 

[21] Sorensen H, Mellemkjaer L, Steffensen F, et al. The risk of a diagnosis of cancer after

[22] Prandoni P, Lensing A, Buller HR, et al. Deep-vein thrombosis and the incidence of

[23] Levitan N, Dowlati A, Remick S, et al. Rates of initial and recurrent thromboembolic

[24] Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and

[25] Huerta C, Johansson S, Wallander MA, Garcia Rodriguez LA. Risk factors and short-

[26] Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical

[27] Mousa SA. Low-molecular-weight heparins in thrombosis and cancer: emerging links.

[28] Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep

subsequent symptomatic cancer. *N EnglJMed.* 1992:327:1128-1133.

in the United Kingdom. *Arch Intern Med.* 2007:167:935-943.

patients. Results of meta-analysis. *AnnSurg.* 1988:208:227-240.

venous thrombosis. Blood 100:3484-3488, 2002

2004

2004

300:2277-2285, 2008

23;(1):CD006649.

1998:338:1169-1173.

2000:160:809-815.

*Hamostaseologie.* 2009:29:121-124.

*Thrombolysis.* 2003:16:21-31.

*Medicine.* 1999:78:285-291.

*Cardiovasc Drug Rev.* 2004:22:121-134.

venous thrombosis. *Ann Intern Med.* 1996:125:1-7.

patient. *Semin Thromb Hemost.* 1999;25:137-145.

bleeding complications during anticoagulant treatment in patients with cancer and

venous thrombosis among patients with cancer. Arch Intern Med 164: 1653-1661,

with multiple myeloma treated with thalidomide and chemotherapy: Effects of prophylactic and therapeutic anticoagulation. Br J Haematol 126: 715-721,

angiogenesis inhibitor bevacizumab in cancer patients: A metaanalysis. JAMA

thromboembolism in patients with cancer. *Cochrane Database SystRev.* 2008 Jan

primary deep venous thrombosis or pulmonary embolism. *N EnglJMed.* 

disease among patients with malignancy versus those without malignancy.

pulmonary embolism: a population-based case-control study. *Arch Intern Med.* 

term mortality of venous thromboembolism diagnosed in the primary-care setting


Approaching Venous Thrombosis in General Surgery Patients 195

[60] Kurtoglu M, Buyukkurt CD, Kurtoglu M, et al. Venous thromboembolism prophylaxis

[61] Knudson MM, Lewis FR, Clinton A, et al. Prevention of thromboembolism in trauma

[62] Geerts WH, Jay RM, Code KI, et al.Acomparison of low-dose heparin with low

[63] Vanek VW. Meta-analysis of effectiveness of intermittent pneumatic compression

[64] Norwood SH, McAuley CE, Berne JD, et al. Prospective evaluation of the safety of

[65] Ginzburg E, Cohn SM, Lopez J, Jackowski J, Brown M, Hameed SM; Miami Deep Vein

[66] Neudecker J, Sauerland S, Neugebauer E, et al. The European Association for

[67] Dabrowiecki S, Rose D, Jurkowski P. The influence of laparoscopic

[68] Ljungstrom KG. Is there a need for antithromboembolic prophylaxis during laparoscopic surgery? Not always. J Thromb Haemost 2005; 3:212-213 [69] Blake AM, Toker SI, Dunn E. Deep venous thrombosis prophylaxis is not indicated for

[70] Bergqvist D, Lowe G. Venous thromboembolism in patients undergoing

[71] Montgomery JS, Wolf JS. Venous thrombosis prophylaxis for urological laparoscopy:

[72] Caprini JA, Arcelus JI, Laubach M, et al. Postoperative hypercoagulability and

[73] Caprini JA, Botteman MF, Stephens JM, Nadipelli V, Ewing MM, Brandt S, et al.

[74] Kuderer NM, Khorana AA, Lyman GH, et al: Ameta-analysis and systematic review of

bleeding complications. Cancer 110:1149-1161, 2007

laparoscopic cholecystec-tomy. J Soc Laparosc Surg 2001; 5:215-219

unit (extended series). Ulus Travma Derg. 2003;9:37–44

major trauma. N Engl J Med. 1996;335:701– 707

hemorrhagic injuries. Arch. Surg. 2002;137: 696–702

laparoscopic surgery. Surg Endosc 2002; 16:1121-1143

patients. J Trauma 1994;37:480–487

1998;64:1050–1058

Nov;90(11):1338-44.

Fibrinol 1997; 8:1-5

162:2173-2176

1626

9:304-309

6:59-74.

with low molecular weight heparin in polytraumatized patients in intensive care

molecular weight heparin as prophylaxis against venous thromboembolism after

devices with a comparison of thigh-high to knee-high sleeves. Am. Surg.

enoxaparin prophylaxis for venous thromboembolism in patients with intracranial

Thrombosis Study Group. Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma. Br J Surg. 2003

Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for

cholecystectomy on perioperative blood clotting and fibrinolysis. Blood Coagul

laparoscopic and arthroscopic surgery and in leg casts. Arch Intern Med 2002;

fractionated heparin versus sequential compression devices. J Urol 2005; 173:1623-

deep-vein thrombosis after laparoscopic cholecystectomy. Surg Endosc 1995;

Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health 2003;

the efficacyand safety of anticoagulants as cancer treatment:Impact on survival and


[46] Bergqvist D, Agnelli G, Cohen AT et al (2002) Duration of prophylaxis against venous

[47] Mismetti P, Laporte S, Darmon JY et al (2001) Meta-analysis of low molecular weight

[48] Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism.

[49] Johnson MJ, Walker ID, Sproule MW et al (1999) Abnormal coagulation and deep

[50] Sampson MT, Kakkar AK (2002) Coagulation proteases and human cancer. Biochem

[51] Alcalay A, Wun T, Khatri V et al (2006) Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 24:1112–1118 [52] Yang SS, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC.Symptomatic venous

[53] Lim W, Dentali F, Eikelboom JW, Crowther MA. Metaanalysis: low-molecular-weight

[54] Mahé I, Aghassarian M, Drouet L, et al. Tinzaparin and enoxaparin given at

[55] Douketis J, Cook D, Meade M, et al. Prophylaxis against deep vein thrombosis in

[56] Schmid P, Brodmann D, Fischer AG, Wuillemin WA. Study of bioaccumulation of

[57] Wu CL, Cohen SR, Richman JM, et al. Efficacy of postoperative patient-controlled

[58] Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated

[59] Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology. 2004; 101: 950-959.

study. Arch Intern Med. 2008;168:1805-1812.

function. J Thromb Haemost. 2009;7:552-558.

980

51–54

Surg 88:913–930

Circulation 107:I-9–I-16

Soc Trans 30:201–207

Apr;35(4):881-7.

2006;144:673-684.

2005;103:1079-1088.

586.

197.

thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346:975–

heparin in the prevention of venous thromboembolism in general surgery. Br J

venous thrombosis in patients with advanced cancer. Clin Lab Haematol 21:

thromboembolism in Asian colorectal cancer surgery patients. World J Surg. 2011

heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med.

prophylactic dose for eight days in medical elderly patients with impaired renal function: a comparative pharmacokinetic study. Thromb Haemost. 2007;97:581-

critically ill patients with severe renal insufficiency with the low-molecularweight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT

dalteparin at a prophylactic dose in patients with various degrees of impaired renal

and continuous infusion epidural analgesia versus intravenous patientcontrolled analgesia with opioids: a meta-analysis. Anesthesiology.

patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2003;28:172-


**Part 5** 

**Special Issues** 

